Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 44 | 41 | −3 |
| Shares | 20.6M | 23.3M | +2.70M (+13.1%) |
| Value | $26.8M | $32.4M | +$5.63M (+21.0%) |
New holders (4)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 500,000 | $695.0K | 0.00% |
| Velan Capital Investment Management LP | 140,000 | $194.6K | 0.17% |
| Bailard, Inc. | 28,500 | $39.6K | 0.00% |
| Charles Schwab Investment Management Inc | 24,712 | $34.4K | 0.00% |
Sold out (7)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Oasis Management Co Ltd. | 280,000 | $364.0K |
| Russell Investments Group, Ltd. | 40,195 | $52.3K |
| Eversept Partners, LP | 31,172 | $40.5K |
| Ergoteles LLC | 28,507 | $37.1K |
| Stifel Financial Corp | 14,014 | $18.2K |
| Citigroup Inc | 43 | $56 |
| Advisor Group Holdings, Inc. | 100 | $0 |